Genetic risk factors in Japanese Alzheimer's disease patients: α1-ACT, VLDLR, and ApoE

Neurobiology of Aging

Volumn 19, Issue SUPPL. 1, 1998, Pages

  Yamanaka, H ^a   Kamimura, K ^a   Tanahashi, H ^a   Takahashi, K ^a   Asada, T ^b   Tabira, T ^a  

^a Div of Demyelinating Dis and Aging   (Japan)

^b National Center of Neurology and Psychiatry   (Japan)

Author keywords

1 antichymotrypsin; Alzheimer's discase; Apolipoprotein E; Familial Alzheimer's disease; Risk factor; Very low density lipoprotein receptor

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALZHEIMER DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC DISORDER; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION; RECEPTORS, LDL; RISK FACTORS;

EID: 0031958481     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00035-9     Document Type: Conference Paper

References (16)

1. Chung H., Roberts C. T., Greenberg S., Rebeck G. W., Christie R., Wallace R., Jacob H. J., Hyman B. T. Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease. Ann. Neurol. 39:1996;800-803.
2. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
3. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M. A., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
4. Haines J. L., Pitchard M. L., Saunders A. M., Schildkraut J. M., Growdon J. H., Gaskell P. C., Farrer L. A., Auerbach S. A., Gusella J. F., Locke P. A., Rosi B. L., Yamaoka L., Small G. W., Conneally P. M., Roses A. D., Pericak-Vance M. A. No genetic effect of alpha 1-antichymotrypsin in Alzheimer disease. Genomics. 33:1996;53-56.
5. Jokinen E., Sakai J., Yamamoto T., Hobbs H. H. CGG triple repeat polymorphism in VLDL receptor (VLDL-R) gene. Hum. Mol. Genet. 3:1994;521.
6. Kamboh M. I., Sanghera D. K., Ferrell R. E., DeKosky S. T. APOE 4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nature Genet. 10:1995;486-488.
7. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y-H., Guenette S. Y., Gals D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
8. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
9. Okuizumi K., Onodera O., Namba Y., Ikeda K., Yamamoto T., Seki K., Ueki A., Nanko S., Tanaka H., Takahashi H., Oyanagi K., Mizusawa H., Kanazawa I., Tsuji S. Genetic association of very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genet. 11:1995;207-209.
10. Okuizumi K., Onodera O., Seki K., Tanaka H., Namba Y., Ikeda K., Saunders A. M., Perikac-Vance M. A., Roses A. D., Tsuji S. Lack of association of very low density lipoprotein (VLDL) receptor gene polymorphism with Caucasian Alzheimer's disease. Ann. Neurol. 40:1996;251-254.
11. Okuizumi K., Onodera O., Tanaka H., Kobayashi H., Tsuji S., Takahashi H., Oyanagi K., Seki K., Tanaka M., Naruse S., Miyatake T., Mizusawa H., Kanazawa I. ApoE-ε4 and early-onset Alzheimer's disease. Nature Genet. 7:1994;10-11.
12. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lamnfelt L., Fraser P. E., Rommens J. M., St George-Hyslop P. H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
13. Roses A. D. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med. 47:1996;387-400.
14. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J-F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., St George-Hyslop P. H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
15. Ueki A., Kawano M., Namba Y., Kawakami M., Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163:1993;166-168.
16. Wenham P. R., Price W. H., Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.